Utah Medical Products (UTMD) FCF Margin (2010 - 2026)

Utah Medical Products' FCF Margin history runs 17 years deep, the most recent figure standing at 34.16% for Q1 2026.

• On a quarterly basis, FCF Margin fell 992.0% year-over-year to 34.16% in Q1 2026; TTM through Mar 2026 was 34.69%, a 1.0% decrease from a year earlier, with the FY2025 full-year figure at 37.18%, up 148.0% from the prior year.
• FCF Margin slipped to 34.16% in Q1 2026 per UTMD's latest filing, from 37.24% in the prior quarter.
• Across five years, FCF Margin topped out at 54.89% in Q1 2023 and bottomed at 25.5% in Q2 2024.
• The 5-year median for FCF Margin is 39.02% (2022), against an average of 38.4%.
• Across the five-year window, FCF Margin slumped 1135 bps in 2022 and jumped 1586 bps in 2023, its largest moves.
• Year by year, FCF Margin stood at 41.56% in 2022, then rose by 2 bps to 42.5% in 2023, then retreated by 25 bps to 31.98% in 2024, then advanced by 16 bps to 37.24% in 2025, then retreated by 8 bps to 34.16% in 2026.
• Per Business Quant, the three latest UTMD FCF Margin figures stand at 34.16% (Q1 2026), 37.24% (Q4 2025), and 39.25% (Q3 2025).